Publications
						
					2025
								Rinaldi F., Balboni B., Varignani G., Milordini G., Marotta R., Girotto S., Cavalli A.
								An integrative structural study of RAD52, an emerging target in anticancer drug discovery
								XXIX National Meeting on Medicinal Chemistry of the Italian Chemistry Society
								
							
								
								
								    
										Poster
									
								
								
									Conference
								
								
							
						2025
								Rinaldi F., Balboni B., Girotto S., Cavalli A.
								An integrative structural study of RAD52, an emerging target in anticancer drug discovery
								XXIX National Meeting on Medicinal Chemistry of the Italian Chemistry Society
								
							
								
								
								    
										Poster
									
								
								
									Conference
								
								
							
						2025
								Rinaldi F., Franco P., Veronesi M., Romeo E., Bresciani V., Varignani G., Catalano F., Bernetti M., Masetti M., Langer J. D., Girotto S., Cavalli A.
								Breaking new ground into RAD51–BRC repeats interplay in Homologous Recombination
								Research Square
								
							
								
								
								    
										Article
									
								
								
									E-print Archive
								
								
							
						2025
								Milordini G., Zacco E., Armaos A., Di Palma F., Masi M., Gilodi M., Rupert J., Broglia L., Varignani G., Oneto M., Scotto M., Marotta R., Girotto S., Cavalli A., Tartaglia G.G.
								Computationally-designed aptamers targeting RAD51-BRCA2 interaction inhibit RAD51 nuclear recruitment
								bioRxiv
								
							2025
								Torielli L., Castelli M., Milani F., Heritz J.A., Cayaban S.J., Hernandez J., Serapian S.A., Magni A., Frasnetti E., Doria F., Pirota V., Wengert L.A., Woodford M.R., Lodigiani G., Bergamaschi G., Veronesi M., Bandiera T., Girotto S., Paladino A., Prodromou C., Backe S.J., Bourboulia D., Canciani A., Arrigoni C., Lolicato M., Gestwicki J.E., Mollapour M., Colombo G.
								Design of multi-target peptide modulators for protein chaperone networks
								Structure
								
							2025
								Quaia R., Veronesi M., Anselmi M., Russo D., Penna I., Scarpelli R., Girotto S., Bertozzi F., Duca M., Bandiera T.
								Development of fluorinated fragments into novel modulators of micro-RNA-21 levels
								European School of Medicinal Chemistry – 44th Edition
								
							
								
								
								    
										Poster
									
								
								
									Conference
								
								
							
						2025
								Anselmi M., Russo D., Penna I., Quaia R., Panosetti M., Scarpelli R., Girotto S., Veronesi M., Bertozzi F., Duca M., Bandiera T.
								DISCOVERY OF NOVEL SMALL-MOLECULE MODULATORS OF microRNA-21 IN PANCREATIC CANCER CELLS
								59th International Conference on Medicinal Chemistry
								
							
								
								
								    
										Poster
									
								
								
									Conference
								
								
							
						2025
								Bresciani V., Rinaldi F., Franco P., Girotto S., Cavalli A., Langer J. D., Masetti M., Bernetti M.
								Dissecting the RAD51-BRC4 Interaction Landscape through Integrative Molecular Simulations and Experimental Biophysics
								Journal of Chemical Information and Modeling
								
							
								
								
								    
										Article
									
								
								
									Journal
								
								
							
						2025
								Rinaldi F., Balboni B., Marotta R., Girotto S., Cavalli A.
								Elucidating RAD52 architecture through an integrated structural biology approach
								51st Meeting of the Italian Crystallographic Association
								
							
								
								
								    
										Poster
									
								
								
									Conference
								
								
							
						2025
								Quatraccioni M., Ocello R., Falchi F., Previtali V., Veronesi M., Varignani G., Margaroli N., Masi M., Scarpelli R., Girotto S., Cavalli A.
								In search of small molecules targeting RAD52 for synthetic lethality (P120)- September 14-17, 2025, Parma (Italy)
								XXIX National Meeting on Medicinal Chemistry
								
							
								
								
								    
										Poster
									
								
								
									Conference
								
								
							
						2025
								Bresciani V., Rinaldi F., Franco P., Girotto S., Cavalli A., Langer J. D., Masetti M., Bernetti M.
								Integrating computational and experimental biophysics reveals novel insights into the RAD51-BRC4 interaction
								BiorXiv
								
							2025
								Masi M., Poppi L., Previtali V., Nelson S.R., Wynne K., Varignani G., Falchi F., Veronesi M., Albanesi E., Tedesco D., De Franco F., Ciamarone A., Myers S.H., Ortega J.A., Bagnolini G., Ferrandi G., Farabegoli F., Tirelli N., Di Stefano G., Oliviero G., Walsh N., Roberti M., Girotto S., Cavalli A.
								Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity
								Cell Death Discovery, vol. 11, (no. 1)
								
							2025
								Codino A., Spagnoletti L., Olobardi C., Cuomo A., Santos-Rosa H., Palomba M., Margaroli N., Girotto S., Scarpelli R., Luan S.-L., Crocco E., Bianchini P., Bannister A.J., Gustincich S., Kouzarides T., Rizzo R., Barbieri I., Cremisi F., Vignali R., Pandolfini L.
								METTL9 sustains vertebrate neural development primarily via non-catalytic functions
								Nature Communications, vol. 16, (no. 1)
								
							2025
								Rinaldi F., Bresciani V., Franco P., Veronesi M., Bernetti M., Masetti M., Langer J., Cavalli A., Girotto S.
								Probing the BRC repeats RAD51 interaction by integrating computational and experimental biophysics
								The 49th FEBS Congress
								
							
								
								
								    
										Poster
									
								
								
									Conference
								
								
							
						2025
								Di Martino R.M.C., Russo D., Penna I., Demuro S., Dalle Vedove A., Spagnuolo R., Ottonello G., Bertozzi S.M., Summa M., Desantis J., Valeri A., Pruccoli L., Tripathi S.K., Tarozzi A., Storici P., Girotto S., Bertorelli R., Armirotti A., Cruciani G., Bandiera T., Cavalli A., Bottegoni G.
								Rational optimization of D3R/GSK-3β dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studies
								European Journal of Medicinal Chemistry, vol. 297